EDITAS MEDICINE, INC. Operating Income
EDITAS MEDICINE, INC. (EDIT) reported Operating Income of -$18.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- EDITAS MEDICINE, INC. operating income (loss) for the quarter ending 2026-06-30 was -$18.55M.
- EDITAS MEDICINE, INC. operating income (loss) for the quarter ending 2026-03-31 was -$25.00M.
- EDITAS MEDICINE, INC. operating income (loss) for the quarter ending 2025-12-31 was -$7.75M.
- EDITAS MEDICINE, INC. operating income (loss) for the quarter ending 2025-09-30 was -$24.55M.
- EDITAS MEDICINE, INC. operating income (loss) for fiscal 2025 was -$160.01M.
- EDITAS MEDICINE, INC. operating income (loss) for fiscal 2024 was -$251.15M.
- EDITAS MEDICINE, INC. operating income (loss) for fiscal 2023 was -$169.18M.
- EDITAS MEDICINE, INC. operating income (loss) for fiscal 2022 was -$225.95M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$18.55M 10-Q · filed 2026-08-05 | -$43.56M 10-Q · filed 2026-08-05 | -$51.31M derived: sum of 3 quarters · filed 2026-08-05 | -$75.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$25.00M 10-Q · filed 2026-05-05 | -$32.76M derived: sum of 2 quarters · filed 2026-05-05 | -$57.31M derived: sum of 3 quarters · filed 2026-05-05 | -$108.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$32.30M derived: sum of 2 quarters · filed 2026-03-09 | -$83.85M derived: sum of 3 quarters · filed 2026-08-05 | -$160.01M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$24.55M 10-Q · filed 2025-11-10 | -$76.09M derived: sum of 2 quarters · filed 2026-08-05 | -$152.25M 10-Q · filed 2025-11-10 | -$198.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$51.54M 10-Q · filed 2026-08-05 | -$127.71M 10-Q · filed 2026-08-05 | -$174.30M derived: sum of 3 quarters · filed 2026-08-05 | -$239.97M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$76.16M 10-Q · filed 2026-05-05 | -$122.76M derived: sum of 2 quarters · filed 2026-05-05 | -$188.42M derived: sum of 3 quarters · filed 2026-05-05 | -$260.32M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$46.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$112.26M derived: sum of 2 quarters · filed 2026-03-09 | -$184.16M derived: sum of 3 quarters · filed 2026-03-09 | -$251.15M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$65.67M 10-Q · filed 2025-11-10 | -$137.57M derived: sum of 2 quarters · filed 2025-11-10 | -$204.56M 10-Q · filed 2025-11-10 | -$228.52M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$71.90M 10-Q · filed 2025-08-12 | -$138.89M 10-Q · filed 2025-08-12 | -$162.86M derived: sum of 3 quarters · filed 2025-08-12 | -$213.02M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$66.99M 10-Q · filed 2025-05-12 | -$90.95M derived: sum of 2 quarters · filed 2025-05-12 | -$141.12M derived: sum of 3 quarters · filed 2025-05-12 | -$185.21M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$23.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$74.13M derived: sum of 2 quarters · filed 2025-03-05 | -$118.22M derived: sum of 3 quarters · filed 2025-03-05 | -$169.18M 10-K · filed 2025-03-05 |
| 2023-09-30 | -$50.16M 10-Q · filed 2024-11-04 | -$94.26M derived: sum of 2 quarters · filed 2024-11-04 | -$145.22M 10-Q · filed 2024-11-04 | -$208.66M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | -$44.09M 10-Q · filed 2024-08-07 | -$95.06M 10-Q · filed 2024-08-07 | -$158.50M derived: sum of 3 quarters · filed 2025-03-05 | -$216.02M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | -$50.96M 10-Q · filed 2024-05-08 | -$114.41M derived: sum of 2 quarters · filed 2025-03-05 | -$171.93M derived: sum of 3 quarters · filed 2025-03-05 | -$226.16M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | -$63.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$120.97M derived: sum of 2 quarters · filed 2025-03-05 | -$175.20M derived: sum of 3 quarters · filed 2025-03-05 | -$225.95M 10-K · filed 2025-03-05 |
| 2022-09-30 | -$57.52M 10-Q · filed 2023-11-03 | -$111.75M derived: sum of 2 quarters · filed 2023-11-03 | -$162.50M 10-Q · filed 2023-11-03 | -$204.11M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$54.23M 10-Q · filed 2023-08-02 | -$104.98M 10-Q · filed 2023-08-02 | -$146.59M derived: sum of 3 quarters · filed 2024-02-28 | -$185.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$50.75M 10-Q · filed 2023-05-05 | -$92.36M derived: sum of 2 quarters · filed 2024-02-28 | -$131.61M derived: sum of 3 quarters · filed 2024-02-28 | -$187.01M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$41.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$80.86M derived: sum of 2 quarters · filed 2024-02-28 | -$136.26M derived: sum of 3 quarters · filed 2024-02-28 | -$193.15M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$39.25M 10-Q · filed 2022-11-02 | -$94.65M derived: sum of 2 quarters · filed 2022-11-02 | -$151.54M 10-Q · filed 2022-11-02 | -$217.41M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$55.40M 10-Q · filed 2022-08-03 | -$112.28M 10-Q · filed 2022-08-03 | -$178.16M derived: sum of 3 quarters · filed 2023-02-22 | -$169.17M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$56.88M 10-Q · filed 2022-05-04 | -$122.75M derived: sum of 2 quarters · filed 2023-02-22 | -$113.77M derived: sum of 3 quarters · filed 2023-02-22 | -$145.10M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | -$65.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$56.88M derived: sum of 2 quarters · filed 2023-02-22 | -$88.22M derived: sum of 3 quarters · filed 2023-02-22 | -$134.84M 10-K · filed 2023-02-22 |
| 2020-09-30 | $8.99M 10-Q · filed 2021-11-09 | -$22.35M derived: sum of 2 quarters · filed 2021-11-09 | -$68.97M 10-Q · filed 2021-11-09 | -$108.39M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$31.34M 10-Q · filed 2021-08-05 | -$77.96M 10-Q · filed 2021-08-05 | -$117.38M derived: sum of 3 quarters · filed 2022-02-24 | -$151.97M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$46.62M 10-Q · filed 2021-05-06 | -$86.04M derived: sum of 2 quarters · filed 2022-02-24 | -$120.63M derived: sum of 3 quarters · filed 2022-02-24 | -$156.28M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$39.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$74.01M derived: sum of 2 quarters · filed 2022-02-24 | -$109.66M derived: sum of 3 quarters · filed 2022-02-24 | -$140.92M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$34.59M 10-Q · filed 2020-11-06 | -$70.24M derived: sum of 2 quarters · filed 2020-11-06 | -$101.50M 10-Q · filed 2020-11-06 | -$127.75M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | -$35.65M 10-Q · filed 2020-08-07 | -$66.91M 10-Q · filed 2020-08-07 | -$93.16M derived: sum of 3 quarters · filed 2020-08-07 | -$109.42M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | -$31.26M 10-Q · filed 2020-05-08 | -$57.52M derived: sum of 2 quarters · filed 2020-05-08 | -$73.77M derived: sum of 3 quarters · filed 2020-05-08 | -$113.43M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | -$26.25M 10-K · filed 2019-03-01 | -$42.51M derived: sum of 2 quarters · filed 2019-11-12 | -$82.17M derived: sum of 3 quarters · filed 2019-11-12 | -$113.73M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$16.26M 10-Q · filed 2019-11-12 | -$55.91M derived: sum of 2 quarters · filed 2019-11-12 | -$87.47M 10-Q · filed 2019-11-12 | -$123.92M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | -$39.66M 10-Q · filed 2019-08-07 | -$71.22M 10-Q · filed 2019-08-07 | -$107.66M derived: sum of 3 quarters · filed 2020-02-26 | -$134.41M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$31.56M 10-Q · filed 2019-05-08 | -$68.00M derived: sum of 2 quarters · filed 2020-02-26 | -$94.75M derived: sum of 3 quarters · filed 2020-02-26 | -$120.86M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | -$36.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$63.19M derived: sum of 2 quarters · filed 2020-02-26 | -$89.31M derived: sum of 3 quarters · filed 2020-02-26 | -$119.93M 10-K · filed 2020-02-26 |
| 2017-09-30 | -$26.75M 10-Q · filed 2018-11-08 | -$52.86M derived: sum of 2 quarters · filed 2018-11-08 | -$83.49M 10-Q · filed 2018-11-08 | -$122.47M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$26.11M 10-Q · filed 2018-08-07 | -$56.74M 10-Q · filed 2018-08-07 | -$95.73M derived: sum of 3 quarters · filed 2019-03-01 | -$116.89M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$30.63M 10-Q · filed 2018-05-04 | -$69.61M derived: sum of 2 quarters · filed 2019-03-01 | -$90.78M derived: sum of 3 quarters · filed 2019-03-01 | -$109.98M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$38.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$60.15M derived: sum of 2 quarters · filed 2019-03-01 | -$79.35M derived: sum of 3 quarters · filed 2019-03-01 | -$97.19M 10-K · filed 2019-03-01 |
| 2016-09-30 | -$21.16M 10-Q · filed 2017-11-08 | -$40.37M derived: sum of 2 quarters · filed 2017-11-08 | -$58.20M 10-Q · filed 2017-11-08 | -$70.58M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | -$19.20M 10-Q · filed 2017-08-09 | -$37.04M 10-Q · filed 2017-08-09 | -$49.41M derived: sum of 3 quarters · filed 2018-03-08 | -$56.79M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | -$17.84M 10-Q · filed 2017-05-15 | -$30.21M derived: sum of 2 quarters · filed 2018-03-08 | -$37.59M derived: sum of 3 quarters · filed 2018-03-08 | -$47.99M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | -$12.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$19.75M derived: sum of 2 quarters · filed 2018-03-08 | -$30.15M derived: sum of 3 quarters · filed 2018-03-08 | -$35.31M 10-K · filed 2018-03-08 |
| 2015-09-30 | -$7.38M 10-Q · filed 2016-11-09 | -$17.78M derived: sum of 2 quarters · filed 2016-11-09 | -$22.94M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$10.40M 10-Q · filed 2016-08-10 | -$15.56M 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | -$5.16M 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | -$12.72M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |